Navigating Cancer’s, Dr. Amila Patel, Provides Insight on Racial Disparities in Recent Cancer Treatment Study

Navigating Cancer, Chief Clinical & Strategy Officer, Dr. Amila Patel, PharmD, BCOP, recently presented data on key findings from a recent abstract with Duke Health revealing racial disparities among head and neck cancer populations at the 2022 American Society of Clinical Oncology conference.

Our research, along with our partners at Duke Health, found there were significant health care delays for people of color when they tried to obtain immunotherapy treatment. Delays related to timeliness in obtaining treatment can be complex and multifactorial and cause differential access to treatment.

Watch Dr. Patel’s AJMC interview, where she discusses key research findings and provides insight into how Navigating Cancer is identifying actionable areas to improve health equity through our integrated platform.

Dr. Patel mentions that here at Navigating Cancer, “We’re trying to address this by screening patients for the other aspects of their life that might impact their ability to receive immunotherapy, such as financial toxicity, mental health screenings, transportation issues.” Addressing these challenges can drastically improve a patient’s oncologic outcomes.

Stay in the Know

Subscribe to the Navigating Cancer blog for the latest news, innovations, and best practices in oncology care.